The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,881,449 in first-year total cost, median $1,440,725.
Most frequent study sections
- Special Emphasis Panel[ZAI1 NVM-A (S1)]2
Most frequent institutions
- EMORY UNIVERSITY1
- SEATTLE BIOMEDICAL RESEARCH INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | CD40L adjuvanted clade C DNA and MVA HIV vaccines1U19AI109633-01 | AMARA, RAMA RAO | EMORY UNIVERSITY, GA | $2,000,000 | ZAI1 |
| 2014 | Eliciting VRC01-like bNAbs by Specifically Designed Env Immunogens1U19AI109632-01 | STAMATATOS, LEONIDAS | SEATTLE BIOMEDICAL RESEARCH INSTITUTE, WA | $881,449 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.